by University of Otago Graphical abstract. Credit: DOI: 10.1111/joim.13348 People using two different inhalers for common chronic lung diseases are more than 50 percent more likely to have a heart attack than those on just one, new University of Otago-led research reveals. Inhaled long-acting muscarinic antagonists (LAMAs) and long-acting beta-agonists (LABAs) are the main drugs used to treat...
